Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuma Mori

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 30, 2023
Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: linear mixed-effects model analysesKazuma Mori, Marenao Tanaka, Itaru Hosaka, et al.
European Heart Journal Open|August 3, 2022
High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general populationYukimura Higashiura, Marenao Tanaka, Kazuma Mori, et al.
Hypertension (Dallas, Tex. : 1979)|August 23, 2021
Distinct Regulation of U-ACE2 and P-ACE2 (Urinary and Plasma Angiotensin-Converting Enzyme 2) in a Japanese General PopulationMasato Furuhashi, Akiko Sakai, Marenao Tanaka, et al.
Biochemical Pharmacology|November 2, 2022
Neuronal differentiation reporter mice as a new methodology for detecting in vivo developmental neurotoxicityKeishi Ishida, Kanoko Tatsumi, Yoshiki Minamigawa, et al.
Journal of Gastroenterology and Hepatology|April 17, 2024
Deciphering metabolic dysfunction-associated steatotic liver disease: insights from predictive modeling and clustering analysisKazuma Mori, Yukinori Akiyama, Marenao Tanaka, et al.
Journal of the American Heart Association|July 8, 2023
Coexistence of Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Kidney Disease Is a More Potent Risk Factor for Ischemic Heart DiseaseDaisuke Miyamori, Marenao Tanaka, Tatsuya Sato, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 2, 2023
An increase in calculated small dense low-density lipoprotein cholesterol predicts new onset of hypertension in a Japanese cohortMarenao Tanaka, Tatsuya Sato, Keisuke Endo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 16, 2023
A high level of thyroid-stimulating hormone is a risk factor for the development of chronic kidney disease in men: a 10-year cohort studyKeisuke Endo, Marenao Tanaka, Tatsuya Sato, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 24, 2024
High Intraocular Pressure Is Independently Associated With New-Onset Systemic Hypertension Over a 10-Year PeriodAraya Umetsu, Marenao Tanaka, Tatsuya Sato, et al.
Scientific Reports|February 28, 2025
Liver fatty acid-binding protein point-of-care testing detects heat-induced organ damage: a pilot study in Japanese male self-defense force personnelHiroyasu Goto, Takuya Ishikiriyama, Kyoko Oe, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 30, 2023
Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: linear mixed-effects model analysesKazuma Mori, Marenao Tanaka, Itaru Hosaka, et al.
European Heart Journal Open|August 3, 2022
High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general populationYukimura Higashiura, Marenao Tanaka, Kazuma Mori, et al.
Hypertension (Dallas, Tex. : 1979)|August 23, 2021
Distinct Regulation of U-ACE2 and P-ACE2 (Urinary and Plasma Angiotensin-Converting Enzyme 2) in a Japanese General PopulationMasato Furuhashi, Akiko Sakai, Marenao Tanaka, et al.
Biochemical Pharmacology|November 2, 2022
Neuronal differentiation reporter mice as a new methodology for detecting in vivo developmental neurotoxicityKeishi Ishida, Kanoko Tatsumi, Yoshiki Minamigawa, et al.
Journal of Gastroenterology and Hepatology|April 17, 2024
Deciphering metabolic dysfunction-associated steatotic liver disease: insights from predictive modeling and clustering analysisKazuma Mori, Yukinori Akiyama, Marenao Tanaka, et al.
Journal of the American Heart Association|July 8, 2023
Coexistence of Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Kidney Disease Is a More Potent Risk Factor for Ischemic Heart DiseaseDaisuke Miyamori, Marenao Tanaka, Tatsuya Sato, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 2, 2023
An increase in calculated small dense low-density lipoprotein cholesterol predicts new onset of hypertension in a Japanese cohortMarenao Tanaka, Tatsuya Sato, Keisuke Endo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 16, 2023
A high level of thyroid-stimulating hormone is a risk factor for the development of chronic kidney disease in men: a 10-year cohort studyKeisuke Endo, Marenao Tanaka, Tatsuya Sato, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 24, 2024
High Intraocular Pressure Is Independently Associated With New-Onset Systemic Hypertension Over a 10-Year PeriodAraya Umetsu, Marenao Tanaka, Tatsuya Sato, et al.
Scientific Reports|February 28, 2025
Liver fatty acid-binding protein point-of-care testing detects heat-induced organ damage: a pilot study in Japanese male self-defense force personnelHiroyasu Goto, Takuya Ishikiriyama, Kyoko Oe, et al.
Pageof 5